S6252
磺胺吡啶
≥99.0%
别名:
4-氨基-N-2-基苯磺酰胺, N1- (吡啶-2-基)磺胺
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C11H11N3O2S
化学文摘社编号:
分子量:
249.29
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
EC Number:
205-642-7
Beilstein/REAXYS Number:
222065
MDL number:
产品名称
磺胺吡啶, ≥99.0%
InChI
1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)
InChI key
GECHUMIMRBOMGK-UHFFFAOYSA-N
SMILES string
Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2
assay
≥99.0%
technique(s)
HPLC: suitable
gas chromatography (GC): suitable
application(s)
forensics and toxicology
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
在使用电化学磁免疫检测技术和高效液相色谱法（HPLC）分别测定牛奶样品和血浆样品中的磺胺吡啶时，磺胺吡啶可用作参考标准品。
有关合适仪器技术的更多信息，请参考产品分析证书。如需进一步支持，请联系技术服务。
General description
磺胺吡啶是柳氮磺吡啶的代谢产物。它是一种抗生素，主要用于治疗类风湿性关节炎。
signalword
Warning
hcodes
Hazard Classifications
Repr. 2
存储类别
11 - Combustible Solids
wgk
WGK 2
Determination of sulfapyridine and its major metabolites in plasma by high-pressure liquid chromatography.
Fischer C and Klotz U.
Journal of Chromatography. B, Biomedical Sciences and Applications, 146(1), 157-162 (1978)
Electrochemical magneto immunosensing of antibiotic residues in milk.
Zacco E, et al.
Biosensors And Bioelectronics, 22(9-10), 2184-2191 (2007)
Fátima Fernández et al.
Biosensors & bioelectronics, 26(4), 1231-1238 (2010-07-20)
Techniques for immunosensing like surface plasmon resonance (SPR) may respond to the need for rapid screening methods to improve food safety. This paper describes the development of a novel portable six channel SPR biosensor based on the plasmon of gold
Cemalettin Alp et al.
Journal of enzyme inhibition and medicinal chemistry, 27(6), 818-824 (2011-12-23)
The inhibition of two human cytosolic carbonic anhydrase (hCA, EC 4.2.1.1) isozymes I, II and human serum isozyme VI, with a series of tosylited aromatic amine derivatives was investigated. The K(I) ranges of compounds 1-14 and acetazolamide against hCA I
Christopher Chidley et al.
Nature chemical biology, 7(6), 375-383 (2011-04-19)
We introduce an approach for detection of drug-protein interactions that combines a new yeast three-hybrid screening for identification of interactions with affinity chromatography for their unambiguous validation. We applied the methodology to the profiling of clinically approved drugs, resulting in
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持